{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:47:46Z","timestamp":1785854866954,"version":"3.56.0"},"reference-count":122,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005046","name":"Natural Science Foundation of Heilongjiang Province","doi-asserted-by":"publisher","award":["LH2019H106"],"award-info":[{"award-number":["LH2019H106"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]},{"name":"\u201cExcellent Young Teachers Basic Research Support Program\u201d for Provincial Undergraduate Colleges in Heilongjiang Province","award":["YQJH2023152"],"award-info":[{"award-number":["YQJH2023152"]}]},{"name":"Heilongjiang Province Traditional Chinese Medicine Research Project","award":["ZHY2025-009"],"award-info":[{"award-number":["ZHY2025-009"]}]},{"name":"Heilongjiang Province Touyan Team, and the Key Laboratory of the Ministry of Education\u2014North Medicine Fundamental and Applied Research Open Fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Sci.","Brain Sciences"],"abstract":"<jats:p>O-linked \u03b2-N-acetylglucosamine modification (O-GlcNAcylation) is a dynamic, nutrient-sensitive post-translational modification that couples hexosamine biosynthesis pathway flux to protein function in neurons and glia. This reversible cycling, catalyzed by O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA), integrates glucose, glutamine, acetyl-CoA, and nucleotide metabolism with synaptic activity, mitochondrial adaptation, transcriptional regulation, proteostasis, and neuroimmune signaling. Dysregulated O-GlcNAc cycling has been implicated in major neurodegenerative diseases, including Alzheimer\u2019s disease (AD), Parkinson\u2019s disease (PD), amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and Huntington\u2019s disease (HD), through effects on disease-related proteins, autophagy, mitochondrial function, and inflammatory networks. However, available evidence does not support a universal model in which global O-GlcNAc elevation is uniformly protective or global reduction is uniformly pathogenic. In this mechanistic narrative review, we integrate disease-specific and substrate-focused findings while distinguishing relatively mature translational evidence from model-based or hypothesis-generating observations. We propose a state-resolved framework in which disease-relevant O-GlcNAc states are interpreted across biological contexts, substrate\/site specificity, and intervention dynamics. This framework helps reconcile divergent findings across experimental systems and highlights the limitations of indiscriminate global pathway modulation. Although OGA inhibitors represent the most advanced therapeutic strategy, their broad substrate effects underscore the need for pharmacodynamic biomarkers, human validation, brain-targeted delivery, and state-resolved approaches. Moving from bulk O-GlcNAc measurements toward precise correction of disease-relevant O-GlcNAc states across defined biological contexts will be essential for translating this biology into clinically meaningful interventions.<\/jats:p>","DOI":"10.3390\/brainsci16080828","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:42:36Z","timestamp":1785850956000},"page":"828","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Brain O-GlcNAcylation in Neurodegenerative Diseases: Context-Dependent Mechanisms and Precision Therapeutic Translation"],"prefix":"10.3390","volume":"16","author":[{"given":"Shaoshuai","family":"Lu","sequence":"first","affiliation":[{"name":"College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyang","family":"Chen","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongsheng","family":"Bian","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Yu","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3937-2891","authenticated-orcid":false,"given":"Lili","family":"Huang","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00726-021-02984-y","article-title":"Post-translational modifications (PTM): Analytical approaches, signaling, physiology and pathophysiology\u2014Part I","volume":"53","author":"Tsikas","year":"2021","journal-title":"Amino Acids"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1016\/S0021-9258(17)43295-9","article-title":"Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc","volume":"259","author":"Torres","year":"1984","journal-title":"J. Biol. Chem."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"12918","DOI":"10.1021\/acs.chemrev.4c00417","article-title":"Opportunities for therapeutic modulation of O-GlcNAc","volume":"124","author":"Cheng","year":"2024","journal-title":"Chem. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1152\/physrev.00043.2019","article-title":"Role of O-linked N-acetylglucosamine protein modification in cellular (patho)physiology","volume":"101","author":"Chatham","year":"2021","journal-title":"Physiol. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/nature05815","article-title":"Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins","volume":"446","author":"Hart","year":"2007","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"9308","DOI":"10.1074\/jbc.272.14.9308","article-title":"Dynamic glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats","volume":"272","author":"Kreppel","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"9838","DOI":"10.1074\/jbc.M010420200","article-title":"Dynamic O-glycosylation of nuclear and cytosolic proteins: Cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain","volume":"276","author":"Gao","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Paneque, A., Fortus, H., Zheng, J., Werlen, G., and Jacinto, E. (2023). The hexosamine biosynthesis pathway: Regulation and function. Genes, 14.","DOI":"10.3390\/genes14040933"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s000180300017","article-title":"A role for N-acetylglucosamine as a nutrient sensor and mediator of insulin resistance","volume":"60","author":"Wells","year":"2003","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/jnc.14242","article-title":"Nutrient-driven O-GlcNAc in proteostasis and neurodegeneration","volume":"144","author":"Akan","year":"2018","journal-title":"J. Neurochem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1038\/s12276-021-00709-5","article-title":"O-GlcNAcylation in health and neurodegenerative diseases","volume":"53","author":"Lee","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3233\/JAD-230955","article-title":"O-GlcNAcylation and its roles in neurodegenerative diseases","volume":"97","author":"Du","year":"2024","journal-title":"J. Alzheimers Dis."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Ong, Q., Han, W., and Yang, X. (2018). O-GlcNAc as an integrator of signaling pathways. Front. Endocrinol., 9.","DOI":"10.3389\/fendo.2018.00599"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-neuro-090919-022842","article-title":"Synaptic plasticity forms and functions","volume":"43","author":"Magee","year":"2020","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/sj.npp.1301559","article-title":"Synaptic plasticity: Multiple forms, functions, and mechanisms","volume":"33","author":"Citri","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/361031a0","article-title":"A synaptic model of memory: Long-term potentiation in the hippocampus","volume":"361","author":"Bliss","year":"1993","journal-title":"Nature"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"44921","DOI":"10.1038\/srep44921","article-title":"Memory and synaptic plasticity are impaired by dysregulated hippocampal O-GlcNAcylation","volume":"7","author":"Yang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13041-023-01072-4","article-title":"Modulation of synaptic transmission through O-GlcNAcylation","volume":"17","author":"Han","year":"2024","journal-title":"Mol. Brain"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1582-4934.2010.01010.x","article-title":"Basic mechanisms of neurodegeneration: A critical update","volume":"14","author":"Jellinger","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrm1742","article-title":"Opinion: What is the role of protein aggregation in neurodegeneration?","volume":"6","author":"Ross","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"16620","DOI":"10.1074\/jbc.RA119.009085","article-title":"O-GlcNAcylation of Thr12\/Ser56 in short-form O-GlcNAc transferase (sOGT) regulates its substrate selectivity","volume":"294","author":"Liu","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"25313","DOI":"10.1074\/jbc.M413819200","article-title":"O-GlcNAcase uses substrate-assisted catalysis: Kinetic analysis and development of highly selective mechanism-inspired inhibitors","volume":"280","author":"Macauley","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1021\/bi052370b","article-title":"Identification of Asp174 and Asp175 as the key catalytic residues of human O-GlcNAcase by functional analysis of site-directed mutants","volume":"45","author":"Macauley","year":"2006","journal-title":"Biochemistry"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/nchembio.520","article-title":"Hijacking a biosynthetic pathway yields a glycosyltransferase inhibitor within cells","volume":"7","author":"Gloster","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"109886","DOI":"10.1016\/j.cbi.2022.109886","article-title":"OGT as potential novel target: Structure, function and inhibitors","volume":"357","author":"Zhang","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e202300001","DOI":"10.1002\/cmdc.202300001","article-title":"Design of OSMI-4 analogs using scaffold hopping: Investigating the importance of the uridine mimic in the binding of OGT inhibitors","volume":"18","author":"Balsollier","year":"2023","journal-title":"ChemMedChem"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cell.2014.06.007","article-title":"Glucose regulates mitochondrial motility via Milton modification by O-GlcNAc transferase","volume":"158","author":"Pekkurnaz","year":"2014","journal-title":"Cell"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/j.devcel.2024.05.008","article-title":"Neuronal activity-driven O-GlcNAcylation promotes mitochondrial plasticity","volume":"59","author":"Yu","year":"2024","journal-title":"Dev. Cell"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1146\/annurev-biochem-060608-102511","article-title":"Cross talk between O-GlcNAcylation and phosphorylation: Roles in signaling, transcription, and chronic disease","volume":"80","author":"Hart","year":"2011","journal-title":"Annu. Rev. Biochem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"E7255","DOI":"10.1073\/pnas.1620529114","article-title":"Elucidating crosstalk mechanisms between phosphorylation and O-GlcNAcylation","volume":"114","author":"Leney","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1242\/jcs.053678","article-title":"The intersections between O-GlcNAcylation and phosphorylation: Implications for multiple signaling pathways","volume":"123","author":"Zeidan","year":"2010","journal-title":"J. Cell Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1016\/j.febslet.2010.04.044","article-title":"Site-specific interplay between O-GlcNAcylation and phosphorylation in cellular regulation","volume":"584","author":"Hu","year":"2010","journal-title":"FEBS Lett."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"13793","DOI":"10.1073\/pnas.0806216105","article-title":"Cross-talk between GlcNAcylation and phosphorylation: Site-specific phosphorylation dynamics in response to globally elevated O-GlcNAc","volume":"105","author":"Wang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbagen.2009.07.018","article-title":"O-linked beta-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress","volume":"1800","author":"Butkinaree","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"ra2","DOI":"10.1126\/scisignal.2000526","article-title":"Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates cytokinesis","volume":"3","author":"Wang","year":"2010","journal-title":"Sci. Signal."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"18961","DOI":"10.1074\/jbc.270.32.18961","article-title":"c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas","volume":"270","author":"Chou","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"38466","DOI":"10.1074\/jbc.M406481200","article-title":"O-GlcNAc transferase is in a functional complex with protein phosphatase 1 catalytic subunits","volume":"279","author":"Wells","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"32944","DOI":"10.1074\/jbc.M503396200","article-title":"Perturbations in O-linked beta-N-acetylglucosamine protein modification cause severe defects in mitotic progression and cytokinesis","volume":"280","author":"Slawson","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.phrs.2016.01.006","article-title":"Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer\u2019s disease","volume":"105","author":"Gatta","year":"2016","journal-title":"Pharmacol. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/brain\/awp099","article-title":"Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer\u2019s disease","volume":"132","author":"Liu","year":"2009","journal-title":"Brain"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"108761","DOI":"10.1016\/j.pharmthera.2024.108761","article-title":"Uncovering the intricacies of O-GlcNAc modification in cognitive impairment: New insights from regulation to therapeutic targeting","volume":"266","author":"Wang","year":"2025","journal-title":"Pharmacol. Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.bbrc.2010.12.080","article-title":"O-GlcNAcylation increases non-amyloidogenic processing of the amyloid-beta precursor protein (APP)","volume":"404","author":"Jacobsen","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13024-017-0181-0","article-title":"Inhibition of O-GlcNAcase leads to elevation of O-GlcNAc tau and reduction of tauopathy and cerebrospinal fluid tau in rTg4510 mice","volume":"12","author":"Hastings","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3233\/JAD-210643","article-title":"Dihydroartemisinin induces O-GlcNAcylation and improves cognitive function in a mouse model of tauopathy","volume":"84","author":"Xia","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1046\/j.1471-4159.1999.0730418.x","article-title":"Glycosylation sites flank phosphorylation sites on synapsin I: O-linked N-acetylglucosamine residues are localized within domains mediating synapsin I interactions","volume":"73","author":"Cole","year":"1999","journal-title":"J. Neurochem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1074\/jbc.M113.512814","article-title":"O-linked beta-N-acetylglucosamine site Thr87 regulates synapsin I localization to synapses and size of the reserve pool of synaptic vesicles","volume":"289","author":"Skorobogatko","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/35016089","article-title":"Regulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity","volume":"405","author":"Lee","year":"2000","journal-title":"Nature"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1523\/JNEUROSCI.4761-12.2014","article-title":"O-GlcNAcylation of AMPA receptor GluA2 is associated with a novel form of long-term depression at hippocampal synapses","volume":"34","author":"Taylor","year":"2014","journal-title":"J. Neurosci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1073\/pnas.1621367114","article-title":"O-GlcNAc transferase regulates excitatory synapse maturity","volume":"114","author":"Hart","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s12035-011-8209-x","article-title":"Genetic approaches to investigate the role of CREB in neuronal plasticity and memory","volume":"44","author":"Barco","year":"2011","journal-title":"Mol. Neurobiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0959-4388(03)00076-X","article-title":"Signaling from synapse to nucleus: The logic behind the mechanisms","volume":"13","author":"Deisseroth","year":"2003","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nchembio.770","article-title":"Dynamic O-GlcNAc modification regulates CREB-mediated gene expression and memory formation","volume":"8","author":"Rexach","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"6612","DOI":"10.1021\/ja028200t","article-title":"Dynamic glycosylation of the transcription factor CREB: A potential role in gene regulation","volume":"125","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s13195-025-01857-w","article-title":"IRF1 ameliorates synaptic dysfunction through the modulation of O-GlcNAcylation on GluN1 subunit of NMDAR","volume":"17","author":"Fan","year":"2025","journal-title":"Alzheimers Res. Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1038\/s41467-021-24301-7","article-title":"Hexosamine biosynthetic pathway and O-GlcNAc-processing enzymes regulate daily rhythms in protein O-GlcNAcylation","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cmet.2012.12.015","article-title":"O-GlcNAc signaling entrains the circadian clock by inhibiting BMAL1\/CLOCK ubiquitination","volume":"17","author":"Li","year":"2013","journal-title":"Cell Metab."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.pneurobio.2010.04.006","article-title":"The synapsins: Key actors of synapse function and plasticity","volume":"91","author":"Cesca","year":"2010","journal-title":"Prog. Neurobiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1750-3639.1993.tb00729.x","article-title":"Synapsin I, synapsin II, and synaptophysin: Marker proteins of synaptic vesicles","volume":"3","author":"Thiel","year":"1993","journal-title":"Brain Pathol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"7430","DOI":"10.1038\/s41467-024-51678-y","article-title":"hnRNP R promotes O-GlcNAcylation of eIF4G and facilitates axonal protein synthesis","volume":"15","author":"Zare","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"R723","DOI":"10.1016\/j.cub.2009.07.047","article-title":"The postsynaptic density","volume":"19","author":"Kim","year":"2009","journal-title":"Curr. Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1074\/mcp.T500040-MCP200","article-title":"O-linked N-acetylglucosamine proteomics of postsynaptic density preparations using lectin weak affinity chromatography and mass spectrometry","volume":"5","author":"Vosseller","year":"2006","journal-title":"Mol. Cell. Proteom."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1074\/mcp.O112.018366","article-title":"Global identification and characterization of both O-GlcNAcylation and phosphorylation at the murine synapse","volume":"11","author":"Trinidad","year":"2012","journal-title":"Mol. Cell. Proteom."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1021\/pr300967y","article-title":"Proteome wide purification and identification of O-GlcNAc-modified proteins using click chemistry and mass spectrometry","volume":"12","author":"Hahne","year":"2013","journal-title":"J. Proteome Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev.neuro.25.112701.142758","article-title":"AMPA receptor trafficking and synaptic plasticity","volume":"25","author":"Malinow","year":"2002","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"6492","DOI":"10.1093\/hmg\/ddv358","article-title":"Mitochondrial ATP synthase activity is impaired by suppressed O-GlcNAcylation in Alzheimer\u2019s disease","volume":"24","author":"Cha","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Isono, T. (2011). O-GlcNAc-specific antibody CTD110.6 cross-reacts with N-GlcNAc2-modified proteins induced under glucose deprivation. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0018959"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1016\/j.febslet.2013.09.042","article-title":"Generation and characterization of a rabbit monoclonal antibody site-specific for tau O-GlcNAcylated at serine 400","volume":"587","author":"Cameron","year":"2013","journal-title":"FEBS Lett."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1002\/cbic.201700515","article-title":"A chemoenzymatic histology method for O-GlcNAc detection","volume":"18","author":"Hou","year":"2017","journal-title":"ChemBioChem"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/path.4929","article-title":"Quantitative proteomics identifies altered O-GlcNAcylation of structural, synaptic and memory-associated proteins in Alzheimer\u2019s disease","volume":"243","author":"Wang","year":"2017","journal-title":"J. Pathol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1038\/s41380-025-02943-z","article-title":"Brain O-GlcNAcylation: Bridging physiological functions, disease mechanisms, and therapeutic applications","volume":"30","author":"Chen","year":"2025","journal-title":"Mol. Psychiatry"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.1073\/pnas.100471497","article-title":"The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny","volume":"97","author":"Shafi","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1128\/MCB.24.4.1680-1690.2004","article-title":"Ogt-dependent X-chromosome-linked protein glycosylation is a requisite modification in somatic cell function and embryo viability","volume":"24","author":"Zachara","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"110277","DOI":"10.1016\/j.cellsig.2022.110277","article-title":"Dynamic regulation of O-GlcNAcylation and phosphorylation on STAT3 under hypoxia-induced EMT","volume":"93","author":"Fu","year":"2022","journal-title":"Cell. Signal."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"12621","DOI":"10.1074\/jbc.M117.790097","article-title":"Mutations in N-acetylglucosamine (O-GlcNAc) transferase in patients with X-linked intellectual disability","volume":"292","author":"Willems","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/1873-3468.13640","article-title":"A missense mutation in the catalytic domain of O-GlcNAc transferase links perturbations in protein O-GlcNAcylation to X-linked intellectual disability","volume":"594","author":"Pravata","year":"2020","journal-title":"FEBS Lett."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"14961","DOI":"10.1073\/pnas.1900065116","article-title":"Catalytic deficiency of O-GlcNAc transferase leads to X-linked intellectual disability","volume":"116","author":"Pravata","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.cell.2016.07.008","article-title":"Phase transition in postsynaptic densities underlies formation of synaptic complexes and synaptic plasticity","volume":"166","author":"Zeng","year":"2016","journal-title":"Cell"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/s41557-022-00946-9","article-title":"O-GlcNAcylation modulates liquid-liquid phase separation of SynGAP\/PSD-95","volume":"14","author":"Lv","year":"2022","journal-title":"Nat. Chem."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0896-6273(00)80809-0","article-title":"Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor\/PSD-95\/GKAP complex and cortactin","volume":"23","author":"Naisbitt","year":"1999","journal-title":"Neuron"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cell.2009.01.050","article-title":"The postsynaptic density proteins Homer and Shank form a polymeric network structure","volume":"137","author":"Hayashi","year":"2009","journal-title":"Cell"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrn1517","article-title":"PDZ domain proteins of synapses","volume":"5","author":"Kim","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1046\/j.1471-4159.2002.00931.x","article-title":"ProSAP\/Shank proteins\u2014A family of higher order organizing molecules of the postsynaptic density with an emerging role in human neurological disease","volume":"81","author":"Boeckers","year":"2002","journal-title":"J. Neurochem."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Leblond, C.S., Nava, C., Polge, A., Gauthier, J., Huguet, G., Lumbroso, S., Giuliano, F., Stordeur, C., Depienne, C., and Mouzat, K. (2014). Meta-analysis of SHANK mutations in autism spectrum disorders: A gradient of severity in cognitive impairments. PLoS Genet., 10.","DOI":"10.1371\/journal.pgen.1004580"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41419-026-08862-3","article-title":"O-GlcNAcylation reprograms microglial inflammatory states and attenuates Alzheimer\u2019s disease pathology","volume":"17","author":"Kim","year":"2026","journal-title":"Cell Death Dis."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41419-024-06670-1","article-title":"Protective effect of increased O-GlcNAc cycling against 6-OHDA induced Parkinson\u2019s disease pathology","volume":"15","author":"Kim","year":"2024","journal-title":"Cell Death Dis."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41531-026-01319-6","article-title":"O-GlcNAcylation regulates microglial neuroinflammation in Parkinson\u2019s disease","volume":"12","author":"Kim","year":"2026","journal-title":"npj Park. Dis."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12974-024-03179-4","article-title":"Chronic rapid eye movement sleep deprivation aggravates the pathogenesis of Alzheimer\u2019s disease by decreasing brain O-GlcNAc cycling in mice","volume":"21","author":"Kim","year":"2024","journal-title":"J. Neuroinflamm."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Alzheimer\u2019s Association (2024). 2024 Alzheimer\u2019s disease facts and figures. Alzheimers Dement., 20, 3708\u20133821.","DOI":"10.1002\/alz.13809"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/01616412.2015.1133485","article-title":"Roles of O-GlcNAcylation on amyloid-\u03b2 precursor protein processing, tau phosphorylation, and hippocampal synapses dysfunction in Alzheimer\u2019s disease","volume":"38","author":"Zheng","year":"2016","journal-title":"Neurol. Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"15120","DOI":"10.1073\/pnas.1606899113","article-title":"Loss of O-GlcNAc glycosylation in forebrain excitatory neurons induces neurodegeneration","volume":"113","author":"Wang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1124\/jpet.120.266122","article-title":"MK-8719, a novel and selective O-GlcNAcase inhibitor that reduces the formation of pathological tau and ameliorates neurodegeneration in a mouse model of tauopathy","volume":"374","author":"Wang","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e70020","DOI":"10.1002\/trc2.70020","article-title":"Discovery and clinical translation of ceperognastat, an O-GlcNAcase (OGA) inhibitor, for the treatment of Alzheimer\u2019s disease","volume":"10","author":"Kielbasa","year":"2024","journal-title":"Alzheimers Dement. (N. Y.)"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1093\/brain\/awaa320","article-title":"O-GlcNAcylation regulates dopamine neuron function, survival and degeneration in Parkinson disease","volume":"143","author":"Lee","year":"2020","journal-title":"Brain"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nchem.2361","article-title":"O-GlcNAc modification blocks the aggregation and toxicity of the protein alpha-synuclein associated with Parkinson\u2019s disease","volume":"7","author":"Marotta","year":"2015","journal-title":"Nat. Chem."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41589-024-01551-2","article-title":"O-GlcNAc forces an alpha-synuclein amyloid strain with notably diminished seeding and pathology","volume":"20","author":"Balana","year":"2024","journal-title":"Nat. Chem. Biol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1021\/acschemneuro.8b00015","article-title":"Pharmacological inhibition of O-GlcNAcase enhances autophagy in brain through an mTOR-independent pathway","volume":"9","author":"Zhu","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13041-017-0311-1","article-title":"O-GlcNAc regulation of autophagy and alpha-synuclein homeostasis; implications for Parkinson\u2019s disease","volume":"10","author":"Wani","year":"2017","journal-title":"Mol. Brain"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1021\/acschemneuro.4c00301","article-title":"O-GlcNAc modification of alpha-synuclein can alter monomer dynamics to control aggregation kinetics","volume":"15","author":"Gamage","year":"2024","journal-title":"ACS Chem. Neurosci."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e202300649","DOI":"10.1002\/chem.202300649","article-title":"Chemical synthesis of alpha-synuclein proteins via solid-phase peptide synthesis and native chemical ligation","volume":"29","author":"Gatzemeier","year":"2023","journal-title":"Chem. Eur. J."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","article-title":"Amyotrophic lateral sclerosis","volume":"400","author":"Feldman","year":"2022","journal-title":"Lancet"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/ene.14393","article-title":"Amyotrophic lateral sclerosis: A clinical review","volume":"27","author":"Masrori","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Mejzini, R., Flynn, L.L., Pitout, I.L., Fletcher, S., Wilton, S.D., and Akkari, P.A. (2019). ALS genetics, mechanisms, and therapeutics: Where are we now?. Front. Neurosci., 13.","DOI":"10.3389\/fnins.2019.01310"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/bmb\/ldw026","article-title":"Pathogenesis of amyotrophic lateral sclerosis","volume":"119","author":"Morgan","year":"2016","journal-title":"Br. Med. Bull."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neulet.2012.04.018","article-title":"Reduced protein O-glycosylation in the nervous system of the mutant SOD1 transgenic mouse model of amyotrophic lateral sclerosis","volume":"516","author":"Shan","year":"2012","journal-title":"Neurosci. Lett."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"10351","DOI":"10.1073\/pnas.0503862102","article-title":"Altered axonal architecture by removal of the heavily phosphorylated neurofilament tail domains strongly slows superoxide dismutase 1 mutant-mediated ALS","volume":"102","author":"Lobsiger","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"20845","DOI":"10.1074\/jbc.271.34.20845","article-title":"Cytoplasmic O-GlcNAc modification of the head domain and the KSP repeat motif of the neurofilament protein neurofilament-H","volume":"271","author":"Dong","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_108","first-page":"1626","article-title":"NPGPx (GPx7): A novel oxidative stress sensor\/transmitter with multiple roles in redox homeostasis","volume":"8","author":"Chen","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.celrep.2019.10.053","article-title":"NPGPx-mediated adaptation to oxidative stress protects motor neurons from degeneration in aging by directly modulating O-GlcNAcase","volume":"29","author":"Hsieh","year":"2019","journal-title":"Cell Rep."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"e51649","DOI":"10.15252\/embr.202051649","article-title":"O-GlcNAcylation of TDP-43 suppresses proteinopathies and promotes TDP-43\u2019s mRNA splicing activity","volume":"22","author":"Zhao","year":"2021","journal-title":"EMBO Rep."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ene.13413","article-title":"Huntington\u2019s disease: A clinical review","volume":"25","author":"McColgan","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neuron.2017.03.023","article-title":"Mutant huntingtin disrupts the nuclear pore complex","volume":"94","author":"Grima","year":"2017","journal-title":"Neuron"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nature12537","article-title":"Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation","volume":"502","author":"Erickson","year":"2013","journal-title":"Nature"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Fleisher, A.S., Munsie, L., Mancini, M., Cheng, Y.-J., Guo, J., Nuthall, H., Otero, D.S., Kotari, V., Kielbasa, W., and Hutton, M. (2026). Ceperognastat in early symptomatic Alzheimer disease: A randomized clinical trial. JAMA.","DOI":"10.1001\/jama.2026.12768"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.conb.2021.09.005","article-title":"PTEN-induced kinase 1 (PINK1) and Parkin: Unlocking a mitochondrial quality control pathway linked to Parkinson\u2019s disease","volume":"72","author":"Agarwal","year":"2022","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Alghusen, I.M., Carman, M.S., Wilkins, H.M., Strope, T.A., Gimore, C., Fedosyuk, H., Shawa, J., Ephrame, S.J., Denson, A.R., and Wang, X. (2024). O-GlcNAc impacts mitophagy via the PINK1-dependent pathway. Front. Aging Neurosci., 16.","DOI":"10.3389\/fnagi.2024.1387931"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e16302","DOI":"10.1111\/jnc.16302","article-title":"Brain transcriptome changes associated with an acute increase of protein O-GlcNAcylation and implications for neurodegenerative disease","volume":"169","author":"Bell","year":"2025","journal-title":"J. Neurochem."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cell.2022.12.016","article-title":"Dual-specificity RNA aptamers enable manipulation of target-specific O-GlcNAcylation and unveil functions of O-GlcNAc on beta-catenin","volume":"186","author":"Zhu","year":"2023","journal-title":"Cell"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"9779","DOI":"10.1021\/jacs.3c14380","article-title":"Targeted protein O-GlcNAcylation using bifunctional small molecules","volume":"146","author":"Ma","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/s41594-019-0325-8","article-title":"Genetic recoding to dissect the roles of site-specific protein O-GlcNAcylation","volume":"26","author":"Gorelik","year":"2019","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41557-021-00648-8","article-title":"O-GlcNAc modification of small heat shock proteins enhances their anti-amyloid chaperone activity","volume":"13","author":"Balana","year":"2021","journal-title":"Nat. Chem."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1021\/acschembio.5c00684","article-title":"Ligand-directed self-assembling chimeras for targeted protein O-GlcNAcylation","volume":"20","author":"Guo","year":"2025","journal-title":"ACS Chem. Biol."}],"container-title":["Brain Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3425\/16\/8\/828\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:50:54Z","timestamp":1785851454000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3425\/16\/8\/828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":122,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["brainsci16080828"],"URL":"https:\/\/doi.org\/10.3390\/brainsci16080828","relation":{},"ISSN":["2076-3425"],"issn-type":[{"value":"2076-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]}}}